UNOV vs. CVSE

Last updated Jun 4, 2026

UNOV (Innovator U.S. Equity Ultra Buffer ETF - November) and CVSE (Calvert US Select Equity ETF) are both Large Cap Blend Equities funds. UNOV is passively managed, while CVSE is actively managed. Over the past 3 years, UNOV returned 10.20%/yr vs 13.34%/yr for CVSE. A 0.76 correlation means they provide meaningful diversification when combined. UNOV charges 0.79%/yr vs 0.29%/yr for CVSE.

Performance

UNOV vs. CVSE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovator U.S. Equity Ultra Buffer ETF - November (UNOV) and Calvert US Select Equity ETF (CVSE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

UNOV

• 1D: -0.22%
• 1M: 2.17%
• YTD: 5.40%
• 6M: 5.64%
• 1Y: 13.88%
• 3Y*: 10.20%
• 5Y*: 6.68%
• 10Y*: —

CVSE

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: 0.00%
• 1Y: 8.06%
• 3Y*: 13.34%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

UNOV vs. CVSE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
UNOV Innovator U.S. Equity Ultra Buffer ETF - November	5.40%	9.92%	9.42%	9.44%
CVSE Calvert US Select Equity ETF	0.00%	10.14%	19.11%	13.35%

Correlation

The correlation between UNOV and CVSE is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.38
Correlation (3Y) Calculated over the trailing 3-year period	0.72
Correlation (All Time) Calculated using the full available price history since Feb 2, 2023	0.76

Over the past year, the correlation between UNOV and CVSE has dropped to 0.38 - well below their long-term average of 0.76, suggesting their price drivers have been diverging.

UNOV vs. CVSE - Sectors Allocation Comparison

Sectors	UNOV	CVSE
Technology	36.2%	39.5%
Financial Services	11.9%	16.3%
Communication Services	10.9%	5.1%
Consumer Cyclical	10.1%	7.0%
Healthcare	8.4%	10.3%
Industrials	8.1%	11.3%
Consumer Defensive	4.9%	1.7%
Energy	3.5%	-
Utilities	2.3%	2.5%
Real Estate	1.9%	3.5%
Basic Materials	1.8%	2.7%

Return for Risk

UNOV vs. CVSE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UNOV

UNOV Risk / Return Rank: 77
UNOV Sharpe Ratio Rank: 77
UNOV Sortino Ratio Rank: 81
UNOV Omega Ratio Rank: 84
UNOV Calmar Ratio Rank: 63
UNOV Martin Ratio Rank: 78

CVSE

CVSE Risk / Return Rank: 46
CVSE Sharpe Ratio Rank: 36
CVSE Sortino Ratio Rank: 37
CVSE Omega Ratio Rank: 67
CVSE Calmar Ratio Rank: 54
CVSE Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UNOV vs. CVSE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovator U.S. Equity Ultra Buffer ETF - November (UNOV) and Calvert US Select Equity ETF (CVSE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UNOV	CVSE	Difference
Sharpe ratio: Return per unit of total volatility	2.50	1.28	+1.22
Sortino ratio: Return per unit of downside risk	3.63	1.90	+1.73
Omega ratio: Gain probability vs. loss probability	1.51	1.40	+0.11
Calmar ratio: Return relative to maximum drawdown	3.08	2.66	+0.43
Martin ratio: Return relative to average drawdown	15.01	5.71	+9.30
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UNOV vs. CVSE - Sharpe Ratio Comparison

The current UNOV Sharpe Ratio is 2.50, which is higher than the CVSE Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of UNOV and CVSE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	UNOV	CVSE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.50	1.28	+1.22
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.98	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.91	0.92	-0.01

Drawdowns

UNOV vs. CVSE - Drawdown Comparison

The maximum UNOV drawdown since its inception was -13.84%, smaller than the maximum CVSE drawdown of -20.29%. Use the drawdown chart below to compare losses from any high point for UNOV and CVSE.

Drawdown Indicators

	UNOV	CVSE	Difference
Max Drawdown Largest peak-to-trough decline	-13.84%	-20.29%	+6.45%
Max Drawdown (1Y) Largest decline over 1 year	-4.52%	-3.08%	-1.44%
Max Drawdown (3Y) Largest decline over 3 years	-9.10%	-20.29%	+11.19%
Max Drawdown (5Y) Largest decline over 5 years	-9.10%	—	—
Current Drawdown Current decline from peak	-0.22%	-1.68%	+1.46%
Average Drawdown Average peak-to-trough decline	-1.66%	-2.69%	+1.03%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.93%	1.42%	-0.49%

Volatility

UNOV vs. CVSE - Volatility Comparison

Innovator U.S. Equity Ultra Buffer ETF - November (UNOV) has a higher volatility of 1.14% compared to Calvert US Select Equity ETF (CVSE) at 0.00%. This indicates that UNOV's price experiences larger fluctuations and is considered to be riskier than CVSE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UNOV	CVSE	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.14%	0.00%	+1.14%
Volatility (6M) Calculated over the trailing 6-month period	4.67%	0.00%	+4.67%
Volatility (1Y) Calculated over the trailing 1-year period	5.58%	6.49%	-0.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	6.83%	13.87%	-7.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	7.72%	13.87%	-6.15%

UNOV vs. CVSE - Expense Ratio Comparison

UNOV has a 0.79% expense ratio, which is higher than CVSE's 0.29% expense ratio.

Dividends

UNOV vs. CVSE - Dividend Comparison

UNOV has not paid dividends to shareholders, while CVSE's dividend yield for the trailing twelve months is around 0.59%.

Position	TTM	2025	2024	2023
CVSE Calvert US Select Equity ETF	0.59%	0.81%	1.05%	1.22%
UNOV Innovator U.S. Equity Ultra Buffer ETF - November	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both UNOV and CVSE in my portfolio?

UNOV and CVSE have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UNOV or CVSE?

UNOV has higher volatility (1.14%) compared to CVSE (0.00%). In terms of maximum drawdown, UNOV dropped -13.84% vs CVSE's -20.29%.

Which ETF is better, UNOV or CVSE?

On 3-year performance, CVSE leads with 13.34% vs 10.20% for UNOV. On fees, CVSE is cheaper at 0.29% per year. On volatility, CVSE has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, UNOV or CVSE?

Over the 3-year period, CVSE has performed better with a 13.34% return vs 10.20%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, UNOV or CVSE?

CVSE is cheaper with a 0.29% expense ratio, compared with 0.79% for UNOV.

Which ETF pays a higher dividend yield, UNOV or CVSE?

CVSE has the higher dividend yield at 0.59%, compared with 0.00% for UNOV.

What is the main difference between UNOV and CVSE?

They also come from different issuers: Innovator and Calvert. Their fees differ too: 0.79% for UNOV and 0.29% for CVSE.

Which has better risk-adjusted returns?

UNOV currently has the higher Sharpe Ratio (2.50 vs 1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.